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Abstract 
Background: An increasing number of magnetic resonance imaging studies using tract-based spatial statistics (TBSS) have 
reported abnormalities of white matter (WM) in patients with bipolar disorder (BD); however, robust conclusions have proved 
elusive, especially considering some important clinical and demographic factors. The present study performed a quantitative 
meta-analysis of TBSS studies to elucidate the most consistent WM abnormalities in patients with BD. 
Methods: A systematic search was conducted through May 2017 for all TBSS studies comparing the fractional anisotropy 
(FA) between patients with BD and healthy controls (HC). Anisotropic effect size-signed differential mapping (AES-SDM) 
meta-analysis was performed. 
Results: A total of 22 datasets including 556 patients with BD and 623 HC were identified. Significant FA reductions were 
identified in the genu and body of the corpus callosum in patients with BD relative to HC. No regions of increased FA were 
reported. In the subgroup analyses, the FA reduction in the genu of the corpus callosum retained significance in patients with 
BDI, while the FA reduction in the body of the corpus callosum retained significance in euthymic patients with BD. Meta-
regression analysis revealed that the percentage of female patients was negatively correlated with the reduced FA in the 
body of the corpus callosum. 
Limitations: The data acquisition, patient characteristics and clinical variables of the included studies were heterogeneous. 
The small number of DTI studies using TBSS in patients with BDII, and the lack of other clinical information, hindered the 
application of subgroup meta-analyses. 
Conclusion: Our study consistently identified decreased FA in the genu and body of the corpus callosum, which suggested 
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that interhemispheric communication may be the connectivity most affected in patients with BD. 
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Introduction 
Bipolar disorder (BD) is a serious chronic disease characterized by the co-occurrence of manic and depressive symptoms, 
with a worldwide prevalence of approximately 1%1. Two main forms are distinguished in the latest Diagnostic and Statistical 
Manual of Mental Disorders, DSM-5: BD type I (BDI) is the classic manic-depressive disorder, while diagnosis of BD type 
II (BDII) requires at least one episode of major depression and one hypomanic episode2. BD causes severe impairment in 
work role function and a high lifetime suicide risk; thus there is a pressing need for a better understanding of its neural basis. 
Magnetic resonance imaging (MRI) has been a useful way to pursue this, and numerous cerebral morphological and functional 
abnormalities have been reported in patients with BD 3. 
In addition to the structural and functional alterations in multiple brain regions, aberrant connectivity between these 
regions seems to be crucial to the pathogenesis of BD4, 5 Diffusion tensor imaging (DTI) can probe the white matter (WM) 
tracts that form the infrastructure of the connectivity. DTI maps the diffusion of water molecules, and the calculated quantity 
of fractional anisotropy (FA) contains information about the directionality and coherence of neuronal fiber tracts6, 7.  
In studies of patients with BD, however, various regions showing both FA increases and decreases have been reported, for 
example in the prefrontal WM, temporal WM and cingulum bundle 8-10. Performing a meta-analysis is a powerful way to 
integrate the results from many studies in an unbiased way11. Therefore, using voxel-based meta-analysis to detect common 
abnormalities in patients with BD from multiple original studies is of particular importance. To our knowledge there have 
been three published voxel-wise whole-brain meta-analyses of pertinent DTI studies on BD12-14. However, these had some 
technical limitations. First, all three studies integrated both voxel-based analysis (VBA) and tract-based spatial statistics 
(TBSS) techniques to compare WM abnormalities between patients with BD and healthy controls (HC). Although VBA and 
TBSS both explore whole-brain WM alterations, they have inherent methodological differences that make combined meta-
analysis problematic. VBA is relatively straightforward and involves spatial normalization of high-resolution images from all 
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of the studied subjects to the same stereotactic space 15. TBSS was specifically developed to analyze diffusion data, and it 
restricts analysis to the center of major WM tracts by projecting each subject’s FA data onto the mean skeleton, thus 
minimizing the misalignment problems that can arise from regular VBA16, arguably making TBSS a more accurate technique 
for detecting WM abnormalities. Second, given the limited number of reported DTI studies, these previous meta-analyses 
were not able to consider either the potentially different neural alterations in patients with BDI and BDII, or the influence of 
the mood state (manic, depressed, or euthymic) during MRI scanning. Some of the inconsistencies in reported WM findings 
may be due to different selection of patient subtypes. For example, Versace et al. reported FA increase in the left uncinate 
fasciculus, left optic radiation and right anterothalamic radiation and FA decrease in the right uncinate fasciculus in patients 
with BDI compared with HC17. Including patients with both BDI and BDII, Haller et al. reported FA decrease in the ventral 
part of the corpus callosum compared with HC18. Ambrosi et al. reported lower FA in the right inferior longitudinal fasciculus 
(ILF) in patients with BDII directly compared to those with BDI19. These different results may reflect different neural 
pathophysiologies in BDI and BDII, and so it is important to identify their separate neurobiological markers. Now that 
increasing numbers of TBSS studies have reported results that take the BD subtypes into consideration, the time is ripe to 
conduct an updated tract-based spatial meta-analysis to explore how these factors influence WM microstructural abnormalities 
in patients with BD.  
Therefore, the first aim of the present study was to conduct a meta-analysis to identify the most prominent and replicable 
WM microstructural abnormalities associated with BD. We used Anisotropic Effect Size-Signed Differential Mapping (AES-
SDM), a recently-developed meta-analytic technique that has the potential to quantify the reproducibility of neuroimaging 
findings. AES-SDM enables the results from individual studies to be weighted and controlled for multiple moderators 
including demographics, clinical information and imaging factors. AES-SDM has the additional advantage over other meta-
analytical tools that all the information from contributing studies is used in the same map, including both positive, negative 
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and null results20. AES-SDM has been successfully applied in other neuropsychiatric studies using TBSS, including major 
depressive disorder and attention-deficit/hyperactivity disorder21, 22. The second aim of this study was to perform subgroup 
meta-analyses based on some important clinical and demographic factors of BD. The third aim was to perform a multiple 
meta-regression analysis to explore the potential effects of demographic and clinical characteristics on WM microstructural 
differences, taking advantage of AES-SDM’s ability to control for moderators.  
 
Materials and methods 
Inclusion of studies 
We conducted our meta-analysis according to the “Preferred Reporting Items for Systematic Reviews and Meta-Analysis” 
(PRISMA) guidelines 23. PUBMED, Web of Knowledge, MEDLINE, PsycINFO, ERIC, CINAHL, Google Scholar and 
EMBASE were searched by using the following key words: 1) “DTI” <OR> “diffusion tensor imaging” <OR> “TBSS” <OR> 
“tract-based spatial statistics” <OR> “fractional anisotropy”, and 2) “bipolar disorder” <OR> “bipolar depression” <OR> 
“mania” to identify relevant articles published up to May 2017. In addition, reference lists of the retrieved articles were 
manually checked for additional relevant studies.  
The inclusion criteria for the study selections were as follows: 1) studies that compared whole-brain FA alteration between 
patients with BD who were diagnosed according to the DSM-IV criteria and HC; 2) studies that used the TBSS approach for 
DTI data analysis; 3) studies that reported Montreal Neurological Institute (MNI) or Talairach coordinates of the whole brain 
contrast of FA; 4) studies were published in English in a peer-reviewed journal; and 5) studies that used significance thresholds 
for data that were either corrected for multiple comparisons or uncorrected with spatial extent thresholds. 
The exclusion criteria were as follows: 1) studies that were case reports or reviews; 2) it proved impossible to obtain the 
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3-dimensional co-ordinates in stereotactic space (MNI or Talairach), even after contacting the study authors; 3) studies that 
reported fewer than ten subjects in either the BD or control groups; 4) studies wherein the patients were explicitly recruited 
to have multiple combined Axis I diagnoses; and 5) the presence of sample overlap with other included studies of larger 
sample sizes. 
 
Quality assessment and data extraction 
Two authors (C.Y and L.L) independently searched the literature, assessed the quality of the retrieved articles and extracted 
and cross-checked the data. In case of disagreement, another author mediated until a consensus was obtained. Study quality 
was assessed using a 12-point checklist (see Appendix, Table S1) that was adapted from previous meta-analytic studies24, and 
considers not only the demographic and clinical characteristics of the individual study subjects (items 1-4) but also the specific 
imaging methodology (items 5-10) and the consistency of the conclusions with the results (items 11, 12). Each item was scored 
as 1, 0.5 or 0 if the criteria were fully met, partially met or unfulfilled, respectively. The quality scores for each study are 
shown in Table 1.  
The following data were extracted from each selected study: the characteristics of the participants and their illness (sample 
size, mean age of the subjects, gender, age at onset, illness duration, symptom severity, diagnosis type, drug status, mood 
states, and comorbidities); MR methodology (magnetic field strength, acquisition voxel size, number of diffusion directions 
and type of analysis); statistical methodology (statistical threshold and correction methods for multiple comparisons); and the 
three-dimensional coordinates (for voxel-level quantitative meta-analyses). 
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AES-SDM method 
Voxel-wise meta-analysis 
For the voxel-wise meta-analysis of the selected studies to detect FA differences in WM between patients with BD and 
HC we used AES-SDM (http://www.sdmproject.com)20. AES-SDM uses effect sizes to combine reported peak coordinates 
that are extracted from databases with statistical parametric maps, and recreates original maps of the effect size of FA 
difference in WM between the patients and controls. The analysis was performed as described in the AES-SDM tutorial and 
related publications25. The MRIcron software was used to visualize AES-SDM maps overlaid on three subgroup analyses onto 
a high-resolution brain template generated by the International Consortium for Brain Mapping.  
The AES-SDM methods are briefly summarized here but have been described in detail elsewhere26, 27. First, the peak 
coordinates of all WM differences at the whole-brain level, and the t-values or z-scores of the regions, were extracted from 
each dataset. Z-scores for significant clusters were straightforwardly converted to t-statistics using an online converter. Studies 
reporting no group differences were also included. To avoid any potential bias toward liberally thresholded regions, the peaks 
that did not appear statistically significant at the whole brain level were excluded 26. Second, the peak coordinates for each 
study were recreated with a standard MNI map of the effect size of the group differences in FA by means of an anisotropic 
Gaussian kernel. We used a relatively wide full-width at half-maximum (FWHM; 20 mm) and DTI-fractional anisotropy 
(TBSS) templates to control false positive results. Findings from studies reporting no group difference were also recreated 
with effect size maps, the difference being that all voxels in the effect size group were estimated to have a null effect size. 
Third, standard meta-analysis was conducted to create a mean map via voxel-wise calculation of the random-effects mean of 
the study maps, taking into account the sample size, intra-study variance and between-study heterogeneity. The analytical 
parameters of the AES-SDM were as follows: voxel threshold p = 0.005, peak height threshold Z = 1.00, and cluster size 
threshold = 100 voxels. 
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Jack-knife sensitivity analysis and subgroup analysis 
To assess the robustness of the findings, we conducted a systematic whole-brain voxel-based jackknife analysis, in which 
we iteratively repeated the analysis excluding 1 dataset at a time to establish to what extent the results could be replicated. If 
a brain region remains significant in all or most of the combinations of studies, the finding is considered highly replicable 26. 
When the sample size was sufficient, sensitivity subgroup analyses were conducted to test the robustness of the statistically 
significant findings of meta-analysis by excluding studies with potential confounds on a one-off basis. We performed subgroup 
analyses of patients with BDI or BDII, with psychotic or non-psychotic symptoms, during euthymic status or depressed status 
or mania status, of adult or pediatric patients compared to HC separately if sufficient datasets were available. We also 
conducted subgroup meta-analysis of studies with corrected results. Jackknife sensitivity analysis was conducted for each 
subgroup result.  
 
Meta-regression analysis 
Meta-regression analyses were performed with age, percentage of female patients, symptom severity (Hamilton 
Depression Scale, HMAD), age at onset and illness duration in each study as the independent variables. Non-drug therapy 
status could not be studied due to a lack of reported data. Symptom severity rated by the Young Mania Rating Scale (YMRS) 
could not be explored by meta-regression because there were only 6 datasets. The results were weighted by the square root of 
the sample size. To minimize the reporting of spurious relationships, we selected a more conservative threshold of 0.0005 as 
was done in previous studies20, requiring abnormalities to be detected both in the slope and in one of the extremes of the 
regressor, and discarded findings in regions other than those detected in the main analyses. The main output for each variable 
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was displayed in a map of the regression slope. Finally, regression plots were visually inspected to discard fittings obviously 
driven by too few studies 26. 
 
Analysis of heterogeneity and publication bias 
Heterogeneity refers to the between-study variances. A between-study heterogeneity analysis of individual clusters was 
conducted using a random-effects model with Q statistics, with the threshold of P = 0.005, peak Z =1 and a cluster extent of 
10 voxels. Areas showing significant heterogeneity that also overlapped with the main findings were explored using meta-
regression analyses to understand the sources of between-study variability. In addition, we assessed publication bias by testing 
funnel plots using Egger’s test via STATA (www.stata.cn), in which any result showing p < 0.05 was regarded as having 
significant publication bias. 
 
Fiber tracking 
The DTIquery software (http://graphics.stanford.edu/projects/dti/) and an atlas of human WM anatomy28 were used to help 
identify the most probable WM tracts passing through the clusters of voxels that showed significant FA group difference. We 
used the sample data of a healthy 35-year-old male provided by the DTIquery software. The WM tracts were mapped using 
streamline tracking techniques and were filtered by tract length and a box-shaped ROI centered on the coordinates of 
significant clusters. 
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Results 
Included studies and sample characteristics 
Systematic search of the databases yielded 883 English research papers. Of these 18 whole-brain TBSS studies with 22 
datasets met our inclusion criteria. Figure 1 shows the flow diagram of selection of studies. The included studies compared 
FA differences in WM between 556 patients with BD (mean age: 38.2 years) and 623 HC (mean age: 39.3 years). Four studies 
reported subgroup comparisons: in one29 drug-free patients with BD and patients treated with lithium alone were compared 
with the same HC group; in another30 patients with BD with and without a history of suicide attempts were compared to the 
same HC group; and two19, 31 included two subgroups of patients with BD, namely, BDI and BDII, which were compared to 
the same HC group. In these four studies, each subgroup comparison was treated as an independent dataset. 
The demographic and clinical characteristics of the samples are reported in Table 1. Of the 556 patients, 57 (10.3%) 
patients were in a manic state at the time of scanning, 162 (29.1%) were depressive, and 232 (41.7%) were euthymic, while 
the mood states of 105 (18.9%) patients were not reported. The patients included 411 with the BDI subtype, 87 with the BDII 
subtype and 58 whose BD subtypes was not mentioned. A total of 165 patients (29.7%) were reported to have comorbidities, 
which included substance abuse, panic disorder, anxiety disorder, post-traumatic stress disorder, obsessive-compulsive 
disorder and attention-deficit hyperactivity disorder, among others. Among the 18 DTI studies, two studies32, 33 involved 36 
adolescents with BD. 
 
Pooled meta-analysis of all included studies 
The pooled meta-analysis of the 22 datasets with 71 clusters revealed decreased FA in the genu of the corpus callosum 
and 2 clusters in the body of the corpus callosum in all patients with BD compared with HC (Figure 2 and Table 2). No regions 
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with increased FA were found. The WM tracts running through these three regions provide interhemispheric connections to 
the prefrontal, orbitofrontal, inferior temporal and superior parietal cortices (Figure 3). These results showed no significant 
between-study heterogeneity (P>0.005). Extraction of funnel plots revealed no publication bias. Egger’s test showed no 
significant publication bias in the genu (Egger’s P = 0.624) and in the anterior (Egger’s P = 0.997) and posterior (Egger’s P = 
0.228) parts of the body of the corpus callosum. 
The whole-brain jackknife sensitivity analysis of the pooled meta-analysis found that all three clusters were highly 
replicable. The most robust cluster was found in the left genu of the corpus callosum, which was preserved throughout all 22 
combinations of the datasets. The other two results in the body of the corpus callosum remained significant in all but 2 and 7 
combinations of the datasets, respectively. 
 
Subgroup meta-analysis   
The subgroup meta-analysis of the studies of patients with BDI included 13 datasets comparing 346 patients with BDI to 
350HC. The FA in patients with BDI was found to be decreased in the genu of the corpus callosum relative to that of HC. 
Subgroup meta-analysis of the studies of patients with BDII compared with HC or patients with BDI was precluded by the 
limited number of datasets. 
The subgroup meta-analysis of euthymic patients with BD included 7 datasets comparing 187 euthymic patients with BD 
to 199 HC. Relative to the HC, patients in the euthymic state exhibited decreased FA in the body of the corpus callosum. 
Subgroup meta-analyses of the manic patients or the depressed patients compared to HC was precluded by the limited number 
of datasets. 
The subgroup meta-analysis of adult patients with BD (age>18 years) included 20 datasets comparing 520 adult patients 
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with BD to 585 HC. The adult patients were found to have decreased FA in the genu and the body of the corpus callosum, 
sharing two clusters with the results of the pooled meta-analysis. Subgroup meta-analysis of adolescent patients was precluded 
by the lack of datasets. 
The subgroup meta-analysis of the studies with corrected results included 19 datasets comprising 513 patients with BD 
and 565 healthy controls. The results were consistent with the pooled meta-analysis (Table S2), showing few effects of the 
uncorrected results on the overall conclusions. 
Only five included studies34, 35 that reported WM alterations in psychotic patients with BD. One study included only 
BD patients with psychosis, and the other 4 studies only reported the percentage of patients with psychosis and did no 
subgroup analysis. The limited number of studies precludes the detection of WM abnormalities comparing psychotic with 
non-psychotic patients with BD. 
 The subgroup jackknife sensitivity analyses of the bipolar subtypes, mood states and adult subjects as well as the corrected 
studies found the meta-analysis results to be highly replicable when focusing only on the BDI, euthymic, adult and corrected 
subgroups.  
 
Meta-regression analysis  
The results of the meta-regression analysis showed that the percentage of female patients with BD that was driven by 21 
datasets was negatively associated with FA reduction in the body of the corpus callosum (p<0.0005, Figure 4). However, the 
results should be interpreted with some caution, seemingly driven by two outlier studies with very high site effects36, 37. No 
effects of the HAMD scores, mean age, age at onset or illness duration on WM alterations were detected. 
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Discussion 
The current study pooled the largest number of TBSS studies to date in patients with BD to conduct a quantitative meta-
analysis. To the best of our knowledge, no similar work has been reported, especially regarding the clinical and demographic 
effects of BD subtypes, psychotic features, mood states, age and gender. Voxel-wise meta-analysis using AES-SDM revealed 
that patients with BD have decreased FA in the genu of the corpus callosum and in two clusters in the body of the corpus 
callosum; these results were robust under jack-knife analysis. A significant negative association was found between the 
percentage of female patients and the FA in the body of the corpus callosum. Subgroup analyses of the BDI studies, euthymic 
studies, and adult studies reproduced the significant findings of decreased FA in the genu and the body of the corpus callosum. 
These results may suggest that abnormalities in WM tracts may be involved in the pathological mechanism of BD.  
The corpus callosum is the largest WM bundle that connects the bilateral cerebral hemispheres, integrating emotional, 
cognitive, motor and sensory functions38-40. We found decreased FA in the genu and body of the corpus callosum in patients 
with BD compared to HC, a finding that was consistent with the findings of two other DTI studies using a region-of-interest 
method focusing on the corpus callosum41, 42. This brain region has been increasingly implicated in patients with BD: for 
example, a multicenter structural MRI study reported decreased mid-sagittal area of the body of the corpus callosum in patients 
with BD compared to HC43. It is tempting to speculate that impaired interhemispheric communication is important in the 
pathophysiology of BD42. The recent meta-analysis by Wise et al. that reported patients with BD showed decreased FA in the 
left cingulum, the left genu of the corpus callosum and the right anterior superior longitudinal fasciculus compared to HC14. 
Our findings are not completely consistent with those of previous meta-analyses, for we found no significant abnormalities in 
any other tracts than corpus callosum. There are several possible reasons for this. First, the previous meta-analyses included 
both TBSS and VBA studies; as mentioned in the Introduction we only included TBSS studies, as there is reason to believe 
that these can more accurately identify WM abnormalities16. Second, we were able to include many more TBSS studies than 
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the previous meta-analyses, thus increasing the precision of effect size estimates. Third, the clinical samples in our included 
studies differed in detail from those in the previous meta-analyses. 
The WM fibers passing through the genu of the corpus callosum connect the bilateral prefrontal cortices, which are known 
to play a role in decision-making, attention, reward processing, and emotion regulation 44, 45. Previous structural studies found 
decreased volume in both the ventral and dorsal prefrontal cortex in patients with BD 46, 47, and several functional studies have 
observed decreased dorsal and ventral prefrontal activity in patients with BD during language tasks and executive-related 
tasks48, 49. Additionally, several studies have reported that the ventral prefrontal cortex is implicated in the “top-down” 
regulation of emotional processing in patients with BD50, 51. The FA reduction in the genu of the corpus callosum in the present 
study suggests impaired prefrontal interhemispheric connectivity, perhaps leading to neurocognitive deficits in e.g. processing 
speed and working memory52, and to emotional dysregulation in patients with BD. Our subgroup analysis of patients with 
BDI reproduced the finding of decreased FA in the genu of corpus callosum compared with HC, which was consistent with 
the findings of some previous DTI studies64, 65. There are clinical differences between BDI and BDII. In the DSM-V, BDI is 
the classic manic-depressive disorder, while BDII features depressive and hypomanic episodes; furthermore, the clinical 
manifestations and treatments are different between BDI and BDII66, 67. FA reduction in the genu of the corpus callosum 
reflected a disconnection of the paralimbic system which plays a central role in emotional regulation3, 68, and might lead to 
manic-type behaviors such as inappropriate euphoria, excessive psychomotor behavior, hypersexuality and paranoia, which 
are consistent with the clinical characteristics of patients with BDI 68. 
The pathobiological interpretation of FA reduction is complex because it can be influenced by many factors, such as 
regional myelination levels, intra- and extracellular volume, the degree of intra-voxel fiber crossing, axonal density and 
average axonal diameter53. Previous studies have suggested that abnormalities in the corpus callosum that are detected early 
in pediatric patients with BD may be due to altered myelination during neurodevelopment54. Meanwhile, several studies have 
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reported a reduction of myelin-producing oligodendrocytes in the prefrontal cortex , in patients with BD55-57. The genu of the 
corpus callosum and the prefrontal cortex are both late-myelinating areas and are therefore more vulnerable to damage than 
the early-myelinating splenium58, 59,60. Thus we speculate that the FA reduction in the genu of the corpus callosum may be 
related to a reduction of myelination, and may result in a pathobiological process that directly slows the transfer of 
interhemispheric information in patients with BD39. To help confirm this hypothesis, further studies with more DTI indices, 
such as axial diffusivity (AD) and radial diffusivity (RD), would be useful, as there is evidence from animal studies that AD 
is primarily an axonal marker and RD is primarily a myelin marker61-63. 
Our finding of decreased FA in the body of the corpus callosum in patients with BD compared with HC was consistent 
with several previous studies69-71. The body of the corpus callosum connects several areas, including the lateral primary motor 
cortex, supplementary motor areas (SMA), primary sensory cortex and parietal cortex72. Previous functional studies showed 
that the rostral part of the SMA, the pre-SMA, is involved in memory storage, learning, transition, and motor and speech 
control, and the pre-SMA connects to the cingulated gyrus, which is part of the limbic system related to cognitive and 
emotional regulation73, while the caudal part of the SMA, the SMA-proper, and the primary motor area are responsible for 
motor function. Together, the SMA may be a transitional region of the limbic and motor system, which plays an important 
role in the translation of emotion into motor actions73. Though emotional dysfunction is one of the main symptom of BD, 
previous studies have shown that patients with BD also have motor impairments such as psychomotor retardation74, agitation75, 
attentional deficits and impairments in fine motor skills 76-79. We therefore suggest that the FA decrease in the body of the 
corpus callosum might be related to motor and emotional dysfunction in patients with BD. Interestingly, our subgroup analyses 
of euthymic patients with BD and adult patients with BD replicated the FA decrease in the body of the corpus callosum. This 
finding was consistent with one previous study which found that euthymic patients with BD had decreased FA in the body of 
the corpus callosum compared to unaffected siblings60. Several studies have reported that brain structural and functional 
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abnormalities are related to current mood states in patients with BD80, 81. Our results may indicate a persistent callosal 
dysconnectivity in euthymic patients with BD, which is consistent with the observation that cognitive impairment and 
executive dysfunction still exist in euthymic patients with BD82, 83.  
 Meta-regression analysis found that FA in the body of the corpus callosum (decreased overall in patients with BD 
compared with HC) was negatively associated with the percentage of female patients. This result may indicate that female 
patients have lower FA values in the body of the corpus callosum than male patients. Sex differences are observed in clinical 
characteristics of BD. Female patients with BD may be more likely to have comorbidities and depressive symptoms which 
may result in high suicide risk and impaired occupational function2. The sex differences of FA in the body of the corpus 
callosum may be related to differences in the clinical aspects of BD. A series of morphological studies reported smaller corpus 
callosum in female patients than in male patients with BD84-86. However, one study reported no significant difference in the 
integrity of the body of the corpus callosum when comparing male with female patients with BD58. These inconsistencies may 
have resulted from the different demographic characteristics, data acquisition methods and other confounding factors in studies 
of patients with BD.  
 Medication exposure is an important potential confounder, and understanding the effect of medications on WM 
abnormalities in patients with BD is critical for the interpretation of results. Because only one primary study enrolled 
unmedicated patients with BD, we could not exclude the confounding influences of medication. Several imaging studies have 
evaluated the effect of psychotropic medications on WM changes in patients with BD. One structural MRI study reported 
larger bilateral temporal lobe WM volumes in patients with BD taking antipsychotic medications than in patients not taking 
antipsychotics87. Among patients with BD, longer duration of lithium treatment is associated with increased FA, suggesting 
that this medication might enhance white matter integrity88. In another study, decreased FA was found in subjects treated with 
lithium, but not in those who were unmedicated; however, there were no significant difference on direct comparison of lithium-
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using with non-lithium-using patients89. It has been reported that lithium and other mood stabilizers can improve WM integrity 
and promote the myelination by acting on neuroglial signaling pathways and by increasing neurotrophic factors90, 91. Further 
studies designed to detect the effect of medication exposure on WM changes in patients with BD are needed. 
 
Limitations 
First, the subjects varied in sociodemographic and clinical characteristics. Although we performed subgroup analyses of 
patients with BDI, euthymic patients with BD, and adult patients with BD, the limited datasets precluded comprehensive 
subgroup analyses (in particular of the important contrast, BDI vs BDII) and meta-regression analyses. Further research is 
needed investigating the contribution of other clinical characteristics, such as age of onset, comorbidities and disorder 
severity. Second, the heterogeneity of MRI image acquisition including voxel size, field intensity of the MR system, 
diffusion direction, and slice thickness, may influence the accuracy of the results of our meta-analysis. Third, the main meta-
analysis included primary studies all except one of which enrolled medicated patients, so the confounding influences of 
medication could not be excluded. Fourth, the meta-regression finding that the percentage of female patients with BD was 
negatively related to the FA in the genu of the corpus callosum was driven by two outlying studies. Fifth, it has been 
reported that more than 50% of patients with BD will experience psychotic symptoms in their lifetime, and it is hard to 
accurately distinguish BD from other psychiatric disorders in patients with psychotic symptoms 92. However, data 
limitations precluded a subgroup analysis of psychotic vs. non-psychotic patients with BD. As 5 of our primary studies 
included psychotic patients with BD, we could not exclude the effects of psychosis features on our results. Future studies 
comparing psychotic versus non-psychotic patients with BD are needed to elucidate this. 
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Conclusion 
We qualitatively and quantitatively reviewed what has become a large number of published TBSS studies on patients with 
BD. Meta-analysis of FA findings found that the most robust and replicable WM differences were in the genu and body of the 
corpus callosum. These WM tracts connect the bilateral frontal, temporal and parietal cortices, indicating the importance of 
disrupted interhemispheric communication in the pathophysiology of BD. Subgroup analyses found WM structural differences 
in patients with BDI, adult and euthymic patients. Furthermore, the results of the meta-regression analysis shed light on the 
structural underpinnings of the sex differences in the clinical manifestations of patients with BD. Attention should be given 
in future studies to the differences in clinical type, mood states, and demographic characteristics, in order to better define the 
neural mechanisms in patients with BD. Differentiating mood- and type-related WM abnormalities is important for elucidating 
the core pathophysiology of BD and will give better insight into the nature of the disease. The present study also adds to the 
development of psychoradiology (https://radiopaedia.org/articles/psychoradiology), the branch of radiology that applies 
clinical imaging to psychiatry and psychology94, 95. 
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